Best for
Mobile
How to buy ADMA Biologics shares | $2.2
Own ADMA Biologics shares in just a few minutes. Share price changes are updated daily.
ADMA Biologics, Inc (ADMA) is a leading biotechnology business based in the US. It opened the day at $2.17 after a previous close of $2.17. During the day the price has varied from a low of $2.11 to a high of $2.235. The latest price was $2.2 (25 minute delay). ADMA Biologics is listed on the NASDAQ and employs 313 staff. All prices are listed in US Dollars.
How to buy shares in ADMA Biologics
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ADMA in this case.
- Research ADMA Biologics shares. The platform should provide the latest information available.
- Buy your ADMA Biologics shares. It's that simple.
What's in this guide?
- Can I buy shares in ADMA Biologics?
- Has coronavirus impacted ADMA Biologics shares?
- ADMA Biologics shares summary
- Compare share dealing platforms
- Is ADMA Biologics stock a buy or sell?
- ADMA Biologics performance over time
- Can I short ADMA Biologics shares?
- ADMA Biologics's financials
- How volatile are ADMA Biologics shares?
- Does ADMA Biologics pay a dividend?
- Other common questions
How has Coronavirus impacted ADMA Biologics's share price?
Since the stock market crash in March caused by coronavirus, ADMA Biologics's share price has had significant negative movement.
Its last market close was $2.24, which is 38.96% down on its pre-crash value of $3.67 and 54.48% up on the lowest point reached during the March crash when the shares fell as low as $1.45.
If you had bought $1,000 worth of ADMA Biologics shares at the start of February 2020, those shares would have been worth $763.10 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $558.61.
ADMA Biologics share price
Use our graph to track the performance of ADMA stocks over time.ADMA Biologics shares at a glance
Information last updated 2020-09-29.
| Open | $2.17 |
|---|---|
| High | $2.235 |
| Low | $2.11 |
| Close | $2.2 |
| Previous close | $2.17 |
| Change | $0.03 |
| Change % | 1.382% |
| Volume | 1,261,213 |
Information last updated 2020-12-27.
| 52-week range | $1.45 - $4.65 |
|---|---|
| 50-day moving average | $1.9924 |
| 200-day moving average | $2.4904 |
| Wall St. target price | $8.29 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.243 |
Invest in ADMA Biologics shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy ADMA Biologics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
ADMA Biologics price performance over time
Historical closes compared with the last close of $2.2
| 1 week (2021-01-14) | 4.27% |
|---|---|
| 1 month (2020-12-22) | -0.90% |
| 3 months (2020-10-22) | -3.93% |
| 6 months (2020-07-22) | -27.15% |
| 1 year (2020-01-21) | -50.45% |
|---|---|
| 2 years (2019-01-18) | -34.52% |
| 3 years (2018-01-19) | -37.85% |
| 5 years (2016-01-21) | -63.33% |
ADMA Biologics financials
| Revenue TTM | $40.3 million |
|---|---|
| Gross profit TTM | $-10,155,155 |
| Return on assets TTM | -21.17% |
| Return on equity TTM | -124.48% |
| Profit margin | -166.01% |
| Book value | $0.796 |
| Market capitalisation | $203.3 million |
TTM: trailing 12 months
How to short and sell ADMA Biologics shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ADMA.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 12.0 million ADMA Biologics shares held short by investors – that's known as ADMA Biologics's "short interest". This figure is 0.2% up from 11.9 million last month.
There are a few different ways that this level of interest in shorting ADMA Biologics shares can be evaluated.
ADMA Biologics's "short interest ratio" (SIR)
ADMA Biologics's "short interest ratio" (SIR) is the quantity of ADMA Biologics shares currently shorted divided by the average quantity of ADMA Biologics shares traded daily (recently around 3.5 million). ADMA Biologics's SIR currently stands at 3.45. In other words for every 100,000 ADMA Biologics shares traded daily on the market, roughly 3450 shares are currently held short.
However ADMA Biologics's short interest can also be evaluated against the total number of ADMA Biologics shares, or, against the total number of tradable ADMA Biologics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ADMA Biologics's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 ADMA Biologics shares in existence, roughly 130 shares are currently held short) or 0.1685% of the tradable shares (for every 100,000 tradable ADMA Biologics shares, roughly 169 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ADMA Biologics.
Find out more about how you can short ADMA Biologics stock.
ADMA Biologics share dividends
We're not expecting ADMA Biologics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
ADMA Biologics share price volatility
Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $1.45 up to $4.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 1.8761. This would suggest that ADMA Biologics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
ADMA Biologics overview
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Frequently asked questions
More guides on Finder
-
How to buy ADMA Biologics shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy ADMA Biologics shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert